Key facts
- BioSolution Designs’s last known valuation is $9.0M.
- It has raised $2.2M across 1 recorded rounds; the latest was Seed Round ($705K) in Mar 2026.
- BioSolution Designs has filed 1 Form D with the SEC, most recently Mar 2026 ($705K sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for BioSolution Designs
Funding rounds
1 roundsAbout BioSolution Designs
Developer of a multigenic therapeutics engine designed to advance gene and cell therapies for complex diseases. The company offers proprietary platforms for creating, controlling, and manufacturing DNA-based therapeutics, enabling researchers and healthcare providers to develop efficient, cost-effective treatments for cardiovascular and other challenging conditions.
- Sector
- Healthcare
- HQ
- Frederick, MD, United States
- Founded
- 2020
- Employees
- 6
- Website
- biodzn.com/
- Ownership
- Privately Held (backing)
BioSolution Designs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioSolution Designs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioSolution Designs in its N-PORT filings yet. We sweep new filings monthly.